Journal article
Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV‐8‐positive, HIV‐negative patient
Abstract
WHAT IS KNOWN AND OBJECTIVE: Human herpesvirus-8 (HHV-8)-positive, HIV-negative multicentric Castleman's disease is a rare lymphoproliferative disorder with no standardized treatment. Concurrent Kaposi's sarcoma, another HHV-8-related disease, is uncommon in HIV-negative patients. The role of antiviral therapy and rituximab in HIV-negative patients is not well established.
CASE DESCRIPTION: We report a case of a 5-year, durable remission of …
Authors
Murphy C; Hawkes E; Chionh F; Chong G
Journal
Journal of Clinical Pharmacy and Therapeutics, Vol. 42, No. 1, pp. 111–114
Publisher
Hindawi
Publication Date
February 2017
DOI
10.1111/jcpt.12472
ISSN
0269-4727